Kistler-Tiffany Companies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $508K | Hold |
1,443
| – | – | 0.08% | 195 |
|
|
2023
Q1 | $455K | Hold |
1,443
| – | – | 0.09% | 176 |
|
|
2022
Q4 | $417K | Hold |
1,443
| – | – | 0.09% | 160 |
|
|
2022
Q3 | $418K | Sell |
1,443
-188
| -12% | -$54.1K | 0.1% | 140 |
|
|
2022
Q2 | $460K | Hold |
1,631
| – | – | 0.1% | 131 |
|
|
2022
Q1 | $426K | Sell |
1,631
-115
| -7% | -$27.3K | 0.08% | 149 |
|
|
2021
Q4 | $383K | Buy |
1,746
+15
| +0.9% | +$2.92K | 0.07% | 142 |
|
|
2021
Q3 | $314K | Buy |
1,731
+34
| +2% | +$6.64K | 0.07% | 145 |
|
|
2021
Q2 | $342K | Sell |
1,697
-369
| -18% | -$77.2K | 0.08% | 142 |
|
|
2021
Q1 | $444K | Buy |
2,066
+633
| +44% | +$139K | 0.11% | 114 |
|
|
2020
Q4 | $339K | Buy |
1,433
+658
| +85% | +$151K | 0.1% | 126 |
|
|
2020
Q3 | $211K | Buy |
775
+148
| +24% | +$40.8K | 0.07% | 141 |
|
|
2020
Q2 | $182K | Sell |
627
-56
| -8% | -$15.2K | 0.06% | 143 |
|
|
2020
Q1 | $150K | Hold |
683
| – | – | 0.05% | 158 |
|
|
2019
Q4 | $150K | Hold |
683
| – | – | 0.05% | 162 |
|
|
2019
Q3 | $116K | Buy |
683
+69
| +11% | +$12.2K | 0.04% | 187 |
|
|
2019
Q2 | $113K | Buy |
614
+13
| +2% | +$2.27K | 0.04% | 182 |
|
|
2019
Q1 | $111K | Hold |
601
| – | – | 0.05% | 182 |
|
|
2018
Q4 | $100K | Hold |
601
| – | – | 0.05% | 175 |
|
|
2018
Q3 | $116K | Hold |
601
| – | – | 0.05% | 176 |
|
|
2018
Q2 | $102K | Sell |
601
-62
| -9% | -$9.61K | 0.05% | 187 |
|
|
2018
Q1 | $108K | Buy |
663
+13
| +2% | +$2.12K | 0.04% | 192 |
|
|
2017
Q4 | $97K | Sell |
650
-15
| -2% | -$2.22K | 0.04% | 207 |
|
|
2017
Q3 | $101K | Hold |
665
| – | – | 0.04% | 199 |
|
|
2017
Q2 | $86K | Sell |
665
-365
| -35% | -$43.9K | 0.04% | 203 |
|
|
2017
Q1 | $113K | Hold |
1,030
| – | – | 0.05% | 175 |
|
|
2016
Q4 | $76K | Hold |
1,030
| – | – | 0.04% | 212 |
|
|
2016
Q3 | $90K | Sell |
1,030
-50
| -5% | -$4.72K | 0.04% | 205 |
|
|
2016
Q2 | $93K | Hold |
1,080
| – | – | 0.05% | 194 |
|
|
2016
Q1 | $86K | Hold |
1,080
| – | – | 0.05% | 199 |
|
|
2015
Q4 | $136K | Hold |
1,080
| – | – | 0.07% | 156 |
|
|
2015
Q3 | $112K | Hold |
1,080
| – | – | 0.07% | 176 |
|
|
2015
Q2 | $133K | Sell |
1,080
-20
| -2% | -$2.52K | 0.08% | 161 |
|
|
2015
Q1 | $130K | Hold |
1,100
| – | – | 0.08% | 146 |
|
|
2014
Q4 | $131K | Hold |
1,100
| – | – | 0.09% | 145 |
|
|
2014
Q3 | $124K | Hold |
1,100
| – | – | 0.08% | 156 |
|
|
2014
Q2 | $104K | Buy |
1,100
+285
| +35% | +$20K | 0.08% | 163 |
|
|
2014
Q1 | $58K | Hold |
815
| – | – | 0.04% | 207 |
|
|
2013
Q4 | $61K | Buy |
815
+215
| +36% | +$15K | 0.05% | 205 |
|
|
2013
Q3 | $45K | Hold |
600
| – | – | 0.04% | 239 |
|
|
2013
Q2 | $48K | Buy |
+600
| New | +$44.2K | 0.04% | 215 |
|
Other funds holding VRTX
Kistler-Tiffany Companies's VRTX Position: Q2 2023 in Review
Kistler-Tiffany Companies held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2023 at 1,443 shares worth $508K. The position accounts for 0.08% of the portfolio, ranked #195.
Kistler-Tiffany Companies first reported a position in VRTX in Q2 2013 and has held it in 41 quarters since. 1,286 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.
- Kistler-Tiffany Companies held 1,443 shares of Vertex Pharmaceuticals worth $508K as of Q2 2023.
- Kistler-Tiffany Companies left its Vertex Pharmaceuticals share count unchanged in Q2 2023.
- Vertex Pharmaceuticals made up 0.08% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #195 holding.
- Kistler-Tiffany Companies first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
- 1,286 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.